{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:38:01Z","timestamp":1791221881336,"version":"4.1.0"},"reference-count":0,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["DDDT"],"DOI":"10.2147\/dddt.s28997","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T23:27:33Z","timestamp":1355182053000},"page":"371","source":"Crossref","is-referenced-by-count":66,"title":["Update on taxane development: new analogs and new formulations"],"prefix":"10.2147","author":[{"given":"Katherine","family":"Tkaczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Yared","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2012,12]]},"container-title":["Drug Design, Development and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=14681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,30]],"date-time":"2016-10-30T22:32:22Z","timestamp":1477866742000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.dovepress.com\/update-on-taxane-development-new-analogs-and-new-formulations-peer-reviewed-article-DDDT"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":0,"URL":"https:\/\/doi.org\/10.2147\/dddt.s28997","relation":{},"ISSN":["1177-8881"],"issn-type":[{"value":"1177-8881","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}